Targeted Strategies for Today's Evolving Markets

MissionIR Blog

VBI Vaccines (VBIV) Presents at Rodman & Renshaw Conference

VBI Vaccines, Inc. (NASDAQ:VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s lead eVLP asset is a prophylactic Cytomegalovirus (“CMV”) vaccine. The company has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and phase I trials. VBI’s second platform is a thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. For more information, visit the company’s website at www.vbivaccines.com

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.